Does polycythemia affect interleukin-6 response pattern in early postnatal period?
Arzu Akdag1, Dilek Dilli, Omer Erdeve
1Department of Neonatology, Zekai Tahir Burak Maternity Teaching Hospital, Ankara, Turkey.
Journal of Clinical Laboratory Analysis
|September 28, 2010
Summary
Neonatal polycythemia is linked to higher interleukin-6 (IL-6) levels in newborns. Partial exchange transfusion (PET) did not significantly alter this IL-6 response pattern, suggesting careful interpretation for sepsis diagnosis.
Area of Science:
- Neonatal Medicine
- Immunology
- Hematology
Background:
- Neonatal polycythemia, a condition of high red blood cell count, may influence inflammatory responses.
- Cytokine production, including interleukin-6 (IL-6), can be elevated in neonates with polycythemia.
Purpose of the Study:
- To investigate the impact of polycythemia and partial exchange transfusion (PET) on interleukin-6 (IL-6) levels in newborns.
- To analyze the IL-6 response pattern in the early neonatal period in infants with and without polycythemia.
Main Methods:
- A study involving 94 newborns, divided into 57 with polycythemia (Group 1) and 37 controls (Group 2).
- Partial exchange transfusion (PET) was administered to Group 1 infants 4-6 hours after birth.
- Blood IL-6 levels were measured at baseline, and at 6 and 24 hours post-PET (or equivalent time in controls).
Main Results:
- Newborns with polycythemia exhibited significantly higher initial and final IL-6 levels compared to controls (P=0.001).
- IL-6 levels in the polycythemia group showed an increase at 6 hours post-PET, followed by a decrease, a pattern mirrored in the control group.
- Elevated IL-6 levels (>70 pg/ml) were rare and not associated with clinical sepsis in either group.
Conclusions:
- Interleukin-6 (IL-6) levels tend to be elevated in newborns with polycythemia during early life, though typically within acceptable limits.
- The observed IL-6 response pattern warrants consideration for refining its diagnostic utility in early-onset neonatal sepsis.
Related Concept Videos
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Lineage Commitment
Commitment is the process whereby stem cells:
Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

